Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Industry Partnerships Are Critical for Successful Dialysis Medtech Disruption

If a small manufacturing organization wants to be a disruptor, embracing industry 4.0 is essential. Marc Nash, VP of Manufacturing at Outset Medical, spoke with DisruptED’s Ron Stefanski on the importance of advanced manufacturing in his organization’s mission to improve dialysis. Experts often told Nash that only sizeable medical device manufacturers could tackle something…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from DisruptED on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

If a small manufacturing organization wants to be a disruptor, embracing industry 4.0 is essential. Marc Nash, VP of Manufacturing at Outset Medical, spoke with DisruptED’s Ron Stefanski on the importance of advanced manufacturing in his organization’s mission to improve dialysis.

Experts often told Nash that only sizeable medical device manufacturers could tackle something as momentous as dialysis, but that is no answer for a disruptor; that’s a challenge.

“You don’t need to have a team of a hundred software developers building out applications for you,” Nash said. “You could start with two or three. You didn’t need monolithic systems that have been out there for a decade. You could take a more agile start-up approach to these projects.”

When Outset Medical started its journey to make an in-home dialysis device, it partnered with Tulip, a frontline operations platform. This partnership helped Outset develop homegrown applications.

“We flipped that paradigm,” Nash said. “We said, we’re going to give it to the process engineers that are going to have to support our operators who build the product, so you better build those applications as good as you can because you’re going to have to support it on the backend. It’s been a huge success thus far.”

Getting employees invested in an advanced manufacturing operation system is essential to its success.

“What we did was brought in not only our managers but our supervisors and employees who work on the floor; we brought them in from day one to learn about the system, for them to participate in designing the different applications we use,” Nash said. “Every single time we release a change to the floor before we release that change, it goes through an operator review to ensure the way we describe it, and the way it’s written is correct, easy for them to understand, and it’s usable.”

DisruptED

Part of this channel

DisruptED

Education, workforce, and manufacturing futures with Ron J. Stefanski.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512